Male Artificial Urinary Sphincter Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

Hospitals is the fastest growing sector, North America is the largest market

The global market for male artificial urinary sphincters is projected to expand from USD 511.77 million in 2025 to USD 672.99 million by 2031, exhibiting a CAGR of 4.67%. This market encompasses implantable medical devices designed to address moderate to severe stress urinary incontinence by replicating the natural function of a healthy urinary sphincter.

Key growth drivers include the increasing incidence of post-prostatectomy incontinence following prostate cancer surgeries and the growing geriatric population susceptible to urological issues, highlighting a strong demand for lasting continence solutions. However, challenges persist, notably the high cost of these devices and the associated risks of surgical revision, mechanical failure, and urethral erosion. These concerns can hinder patient adoption and broader market penetration, despite the significant clinical need underscored by statistics like the 14% to 25% of post-prostatectomy men experiencing bothersome leakage, as reported by the American Urological Association in 2024.

Market Drivers

The primary driver for the Male Artificial Urinary Sphincter Market is the rising incidence of prostate cancer, which directly increases the patient population requiring continence restoration after radical prostatectomy. The American Cancer Society projected 313,780 new prostate cancer cases in the US for 2025, with an annual incidence rate increase of 3% from 2014-2021, underscoring a persistent need for post-surgical incontinence management.

Complementing this, technological advancements are significantly boosting market expansion by improving device reliability and minimizing surgical revision risks. Next-generation artificial sphincters feature enhanced materials and user-friendly components, reducing complications like urethral atrophy and device failure, which in turn promotes greater adoption among clinicians and patients. This innovation is reflected in strong financial outcomes, such as Boston Scientific's MedSurg segment reporting 16.4% sales growth in Q3 2025, validating the market's positive response to sophisticated, reliable incontinence solutions.

Market Challenges

A significant challenge for the Male Artificial Urinary Sphincter Market stems from the devices' vulnerability to mechanical failure and the resulting necessity for surgical revision. The inherent risks of device malfunction, urethral erosion, and infection cause considerable apprehension among both patients and healthcare providers. This concern about repeat invasive procedures often leads eligible patients to choose less invasive management options, thereby diminishing patient confidence and restricting the overall market potential due to reliability uncertainties. Additionally, the high re-operation rate imposes a substantial economic and clinical burden, straining healthcare budgets and reducing the therapy's perceived cost-effectiveness. A 2025 study by the American Urological Association revealed a 29% probability of surgical reintervention within two years of initial implantation, highlighting the ongoing durability issues that discourage widespread adoption of this therapeutic solution.

Market Trends

The market for artificial urinary sphincters is being significantly shaped by two key trends: the integration of smart and electronic AUS systems, and the development of adjustable pressure-regulating mechanisms. Smart and electronic systems are replacing traditional mechanical pumps with automated, patient-specific control, using sensors and algorithms to dynamically adjust cuff pressure.

This innovation minimizes urethral damage while maintaining continence, a shift validated by substantial industry investment, such as UroMems securing $47 million in June 2024 for its UroActive System clinical trials. Simultaneously, advancements in hydraulic engineering are leading to adjustable pressure-regulating mechanisms that dynamically adapt to intra-abdominal pressure changes, preventing tissue atrophy by avoiding constant high static pressure. These design improvements are proving highly reliable, with early studies for Rigicon's ContiReflex system showing a 98% device survival rate at 18 months, offering enhanced alternatives to older designs.

Key Market Players

• Boston Scientific Corporation
• Zephyr Surgical Implants
• Affluent Medical
• UroMems (URO MEMS)
• Rigicon
• ProMinent GmbH
• Coloplast A/S
• Medtronic plc
• Stryker Corporation
• Silimed

Report Scope

In this report, the Global Male Artificial Urinary Sphincter Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Male Artificial Urinary Sphincter Market, by Type:

• AUS with a balloon reservoir (3-component)
• AUS with a spring (2-component)

Male Artificial Urinary Sphincter Market, by End-user:

• Hospitals
• Clinics & Other Healthcare Centers
• Academic & Research Centers

Male Artificial Urinary Sphincter Market, by Region:

• North America
• Europe
• Asia Pacific
• South America
• Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Male Artificial Urinary Sphincter Market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.